Showing results (231-240 of 566) with videos related to
Sort By:
Pageof 57
Clinical Rheumatology|April 16, 2018
Evaluation of disease activity in patients with rheumatoid arthritis treated with tofacitinib by RAPID3: post hoc analyses from two phase 3 trialsVibeke Strand, Eun Bong Lee, Yusuf Yazici, et al.The Journal of Rheumatology|December 17, 2017
Adiposity in Juvenile Psoriatic ArthritisAaida Samad, Matthew L Stoll, Idit Lavi, et al.Frontiers in Medicine|September 22, 2018
Classification and Outcome Measures for Psoriatic ArthritisYing Ying Leung, Alexis Ogdie, Ana-Maria Orbai, et al.BMJ Open|December 25, 2025
Sex differences in the efficacy, safety and persistence of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of phase III and long-term extension trialsVibeke Strand, Hendrik Schulze-Koops, Samar Al-Emadi, et al.Rheumatology International|November 11, 2017
Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology databaseKatinka Albrecht, Dörte Huscher, Frank Buttgereit, et al.Deutsches Arzteblatt International|October 2, 2009
Gout--current diagnosis and treatmentAnne-Kathrin Tausche, Tim L Jansen, Hans-Egbert Schröder, et al.Arthritis Research & Therapy|November 14, 2009
Rapid and sustained improvements in health-related quality of life, fatigue, and other patient-reported outcomes in rheumatoid arthritis patients treated with certolizumab pegol plus methotrexate over 1 year: results from the RAPID 1 randomized controlled trialVibeke Strand, Philip Mease, Gerd R Burmester, et al.Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|August 23, 2020
Pain and Fatigue in Patients With Ankylosing Spondylitis Treated With Tumor Necrosis Factor Inhibitors: Multinational Real-World FindingsVibeke Strand, Atul Deodhar, Rieke Alten, et al.Rheumatology and Therapy|September 20, 2022
Routine Assessment of Patient Index Data 3 (RAPID3) in Patients with Rheumatoid Arthritis Treated with Long-Term Upadacitinib Therapy in Five Randomized Controlled TrialsMartin Bergman, Maya H Buch, Yoshiya Tanaka, et al.Arthritis Research & Therapy|December 10, 2019
Upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs: results from SELECT-NEXTVibeke Strand, Janet Pope, Namita Tundia, et al.Pageof 57